Vivax Bio is a biotechnology and hardware company that specializes in 3D bioprinting. Founded in 2013, the company offers a diverse range of equipment, materials, technologies, and products in the market. They are known for integrating engineering and biological perspectives into their operations, emphasizing the significant advantages of this approach. Their product lineup includes various 3D bioprinters and a wide range of tissue and organ creations, covering both R&D stages and full-scale commercial production. Based in the United States, Vivax Bio presents an innovative solution in the rapidly evolving field of biotechnology, making it an intriguing prospect for potential venture capital investment.
There is no investment information
No recent news or press coverage available for VIVAX BIO .
We care about your data, and we'd love to use cookies make your experience better.
